Synutra Annual Report on Form 10-K Includes 'Going Concern' Explanatory Paragraph fr... (rtain covenants under itsABN Amro loan a...)

Synutra Annual Report on Form 10-K Includes 'Going Concern' Explanatory Paragraph from Auditor

Date:6/19/2009

rtain covenants under its ABN Amro loan agreement.

This announcement is being made in compliance with Nasdaq Marketplace Rule 4350(b)(1)(B), which requires separate disclosure of receipt of an audit opinion that contains a going concern qualification.

Synutra's Forms 10-K are available online: http://www.synutra.com .

About Synutra International, Inc.

Synutra International, Inc. is a leading infant formula company in China. It principally produces, markets and sells its products under the "Shengyuan," or "Synutra," name, together with other complementary brands. It focuses on selling premium infant formula products, which are supplemented by more affordable infant formulas targeting the mass market as well as other nutritional products and ingredients. It sells its products through an extensive nationwide sales and distribution network covering 29 provinces and provincial-level municipalities in China. As of March 31, 2009, this network comprised over 480 distributors and over 800 sub-distributors who sell Synutra products in over 65,000 retail outlets.

    For more information, please contact:

    Weiguo Zhang of Synutra International, Inc.
     Tel:   +1-301-840-3888
     Email: wzhang@synutra.com
     Web:  http://www.synutra.com

    Delia Cannan of Taylor Rafferty
     Tel:   +1-212-889-4350
     Email: synutra@taylor-rafferty.com

SOURCE Synutra International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Nasdaq Informs Synutra that the Companys Filing Delinquency has been Cured
2. Synutra International, Inc. Amends August 2005 Current Report on Form 8-K and Annual Report on Form 10-K for the Fiscal Year Ended March 31, 2007
3. Synutra Provides Progress Update on Recall and Reports Results for the Second Quarter Ended September 30, 2008
4. Synutra Issues Statement Regarding Market Rumors on Revocation of its Production Certification
5. Synutra International, Inc. Sets the Date for its Fourth Quarter and Fiscal Year Earnings Announcement
6. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
7. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
8. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
9. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
10. inVentiv Health to Present at the 20th Annual Bear Stearns Healthcare Conference
11. Annual flu shot cuts need for doctors visits, hospitalization among children

Post Your Comments:

(Date:12/15/2009)... A study in the Dec. 15 issue ... indicates that significant associations exist between parent-reported ... and headaches in young school-aged children. , ... insomnia was 3.3 times more likely in children ... in children with headaches. Nineteen percent of ...

(Date:12/14/2009)... liposuction and fat transfer treatments can help people slim down, ... invasive treatment. , ... (PRWEB) December ... remove excess fat from the abdomen and inject it into ... facial wrinkling and enhance lips all in one safe, minimally ...

(Date:12/14/2009)... -- Haemonetics Corporation (NYSE: HAE ) ... legal action to stop Fenwal Inc.,s continued patent ... collection kits, using a modified separation chamber. ... Haemonetics, patent and the injunction entered by the ... after December 1, 2010. According to statements ...

(Date:12/14/2009)... gene, researchers say , , MONDAY, Dec. 14 (HealthDay News) ... in a single gene linked to heart failure. , ... St. Louis analyzed the DNA of a large group ... variants in four genes that could be connected with ... failure and 625 healthy whites led the researchers to ...

(Date:12/14/2009)... -- Skilled nursing facilities (SNFs) in Ohio are making ... deal with a 92 percent increase in the state-imposed ... $12.01 per bed per day, scheduled for December 15. ... pay an additional $17,520 to the state each month, ... $438,365 yearly. ,, Nearly 96 percent of skilled nursing ...

Breaking Medicine News(10 mins):Health News:Insomnia symptoms linked with medical complaints in young school-aged children 2 Health News:Insomnia symptoms linked with medical complaints in young school-aged children 3 Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 2 Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 3 Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 2 Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 3 Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 2 Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 3

[1] Insomnia symptoms linked with medical complaints in young school-aged children [0] Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling [0] Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement [0] Contributors to Heart Failure Identified [1] Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts

... lead unhealthy lifestyles are more likely to suffer from ... population-based study of more than 5,000 men and women ... journal BJU International. Researchers hope the results will help ... can be managed more effectively. , According to ...

... Third Quarter Revenue Increased 70.9% to $9.2 Million, ... Co., Inc., (OTC Bulletin Board: TYNP), a manufacturer ... in,Chengdu, China, today announced fiscal results for its ... the third quarter of 2008 increased 70.9% to ...

... p.m. ET Thursday, May 22, WESTFORD, Mass., May ... developer and manufacturer of a broad array of,light-based aesthetic ... at the 2008 Citi Investment Research Global Health,Care Conference, ... presentation will be webcast live over the Internet,beginning at ...

... 15 Pain is a chief reason that,patients ... option,for these patients. Physicians must be able to ... for their patients., To make clinicians aware ... the dual journals Current Clinical Practice and The,Journal ...

... in mouse model hint of new treatment strategies for the ... polyunsaturated fat, the kind often found in baked and fried ... , The finding by University of California, Los Angeles, scientists ... a mouse model that closely mimics human cancer. , The ...

... Group (USA), Inc.,(the ,Company, or ,Tiens,), (Amex: TBV ), ... ended March 31, 2008., Revenue for the first quarter ... first quarter of 2007., Net income for the first ... to net income of $6.5 million, or $0.09 per share ...

Obesity and unhealthy lifestyles linked to more complex urinary problems Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2008 Financial Results Cynosure to Present at 2008 Citi Investment Research Global Health Care Conference Treat Your Patients' Pain Effectively Lowering Dietary Fat May Help Prevent Prostate Cancer Tiens Biotech Group (USA) Reports First Quarter Results

(Date:12/14/2009)... THE WOODLANDS, Texas, Dec. 14 /PRNewswire/ ... investigators affiliated with US Oncology ... were presented orally at the ... , held Dec. 9-13 at the ... in San Antonio, Texas . ...

(Date:12/14/2009)... Cardinal Health today announced that executives of ... ,, Goldman Sachs CEO Unplugged Conference ... Sachs Conference Center in New York. 28th ... at Noon EST at the Westin St. Francis Hotel ... executives will discuss Cardinal Health,s diverse products and services, ...

(Date:12/14/2009)... Southridge LLC ("Southridge"), an investment firm that provides ... announce that its affiliated fund has closed a private ... equity financing to Imaging Diagnostic Systems, Inc. (OTCBB: IMDS). ... growth of Imaging Diagnostic Systems, Southridge has paved a ... the field of early breast cancer detection," said Stephen ...

Breaking Medicine Technology:US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 2 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 3 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 4 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 5 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 6 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 7 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 8 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 9 Cardinal Health Executives to Speak at Two Investor Events in January 2 Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc. 2 Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 1 Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 2 Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 3 Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 4 Delta Health an InfoLogix Company Wins Engagement with Hennepin County Medical Center for Strategic Cost Management 56400 1 Delta Health an InfoLogix Company Wins Engagement with Hennepin County Medical Center for Strategic Cost Management 56400 2 Delta Health an InfoLogix Company Wins Engagement with Hennepin County Medical Center for Strategic Cost Management 56400 3 Genova files patent for new prostate cancer treatment 56395 1 Genova files patent for new prostate cancer treatment 56395 2

[0] US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium [0] Cardinal Health Executives to Speak at Two Investor Events in January [0] Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc.

... at AASLD annual meeting, Pivotal Phase III ... failed prior treatment, SAN FRANCISCO, Nov. 1 ... that a planned interim analysis of a,Phase II ... C,protease inhibitor, in combination with peginterferon and ribavirin,markedly ...

... I Clinical Data and Additional Preclinical Results for Non-Nucleoside ... Polymerase Inhibitor Being Presented at AASLD, SAN DIEGO, Nov. ... the results of a Phase I clinical trial,of ANA598 in ... of the leading non-nucleoside polymerase inhibitors,currently in development for the ...

Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers

All welded construction for strength and durability. Choice of stainless steel or chrome plated models....

... Motorized tilt, user programmable memory two ... control on both chair sides, solid ... base. Single button folding armrests and ... handle on both chair sides, ergonomically ...

... A practical, comfortable chair for ... seat height is adjustable from ... by use of an independent ... rotatable through 360 and incorporates ...

Heine Beta 200 Streak Retinoscope 3.5v w/Twist Lock for Welch-Allyn style handles....

Medicine Products:

P-1068-SS Examination Chair OC-2400 MAC-150E Patient Chair Heine Beta 200 Streak Retinoscope 3.5v w/ Twist Lock

Synutra Annual Report on Form 10-K Includes 'Going Concern' Explanatory Paragraph fr...(rtain covenants under itsABN Amro loan a...),Health